← boothcheck

Is DHC overvalued?

boothcheck doesn't label DHC overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, DHC is priced for today's economics sustained for about 5.5 years. The price is justified by relative-multiple; earnings-power/growth-DCF land below the price. The more the price assumes beyond what DIVERSIFIED HEALTHCARE TRUST has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from DIVERSIFIED HEALTHCARE TRUST's SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth
For about5.5 yrs
Margin needed
Margin today
Price vs asset value1.30x
Price vs earnings power9.59x
Price vs peer multiples0.69x
Price vs forward growth1.55x
Read the full DHC report →
Get boothcheck's read on what DHC's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.